BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 31010905)

  • 21. Neurofibromatosis: a guide to care in the community.
    Redmann C
    J Fam Health Care; 2007; 17(3):95-7. PubMed ID: 17849773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurofibromatosis type 1--an update and review for the primary pediatrician.
    Goldberg Y; Dibbern K; Klein J; Riccardi VM; Graham JM
    Clin Pediatr (Phila); 1996 Nov; 35(11):545-61. PubMed ID: 8953130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurofibromatosis type 1 clinical features and management.
    Scalzone M; Coccia P; Ruggiero A; Riccardi R
    Pediatr Med Chir; 2009; 31(6):246-51. PubMed ID: 20333883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurofibromatosis type 1.
    North K
    Am J Med Genet; 2000; 97(2):119-27. PubMed ID: 11180219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pigment cell-related manifestations in neurofibromatosis type 1: an overview.
    De Schepper S; Boucneau J; Lambert J; Messiaen L; Naeyaert JM
    Pigment Cell Res; 2005 Feb; 18(1):13-24. PubMed ID: 15649148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Segmental neurofibromatosis type 1 complicated with multiple intracranial arteriovenous fistulas: A case study.
    He D; Li Y; Yu Y; Cai G; Ouyang F; Lin Y; Lu H; Chu L
    Clin Neurol Neurosurg; 2018 May; 168():108-111. PubMed ID: 29544172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurofibromatosis types 1 and 2.
    Yohay K
    Neurologist; 2006 Mar; 12(2):86-93. PubMed ID: 16534445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neurofibromatosis type 1 in an adult diagnosed by a pulmonologist].
    Gawlewicz-Mroczka A; Mastalerz L; Nizankowska-Mogilnicka E
    Pneumonol Alergol Pol; 2009; 77(5):474-8. PubMed ID: 19890828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1.
    Corsello G; Antona V; Serra G; Zara F; Giambrone C; Lagalla L; Piccione M; Piro E
    Ital J Pediatr; 2018 Apr; 44(1):45. PubMed ID: 29618358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient and physician attitudes regarding clinical trials in neurofibromatosis 1.
    McQueen M; MacCollin M; Gusella J; Plotkin SR
    J Neurosci Nurs; 2008 Dec; 40(6):341-5. PubMed ID: 19170300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NF1 gene and neurofibromatosis 1.
    Rasmussen SA; Friedman JM
    Am J Epidemiol; 2000 Jan; 151(1):33-40. PubMed ID: 10625171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Molecular diagnosis as a strategy for differential diagnosis and at early ages of neurofibromatosis type 1 (NF1)].
    Gómez M; Batista O
    Rev Med Chil; 2015 Oct; 143(10):1320-30. PubMed ID: 26633276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Phenotypic and genetic features in neurofibromatosis type 1 in children].
    Duat Rodríguez A; Martos Moreno GÁ; Martín Santo-Domingo Y; Hernández Martín A; Espejo-Saavedra Roca JM; Ruiz-Falcó Rojas ML; Argente J
    An Pediatr (Barc); 2015 Sep; 83(3):173-82. PubMed ID: 25541118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical hematologic and renal manifestations in neurofibromatosis type I: coincidence or pathophysiological link?
    Van-Gils J; Harambat J; Jubert C; Vidaud D; Llanas B; Perel Y; Lacombe D; Goizet C
    Eur J Med Genet; 2014; 57(11-12):639-42. PubMed ID: 25234363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skeletal muscle and motor deficits in Neurofibromatosis Type 1.
    Summers MA; Quinlan KG; Payne JM; Little DG; North KN; Schindeler A
    J Musculoskelet Neuronal Interact; 2015 Jun; 15(2):161-70. PubMed ID: 26032208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Continuous clinical management of patients with neurofibromatosis type 1].
    Ohno K
    Nihon Rinsho; 2010 Jan; 68(1):131-5. PubMed ID: 20077805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurofibromatosis: part 2--clinical management.
    Batista PB; Bertollo EM; Costa Dde S; Eliam L; Cunha KS; Cunha-Melo JR; Darrigo Junior LG; Geller M; Gianordoli-Nascimento IF; Madeira LG; Mendes HM; Miranda DM; Mata-Machado NA; Morato EG; Pavarino ÉC; Pereira LB; Rezende NA; Rodrigues Lde O; Sette JB
    Arq Neuropsiquiatr; 2015 Jun; 73(6):531-43. PubMed ID: 26083891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The detection of contiguous gene deletions at the neurofibromatosis 1 locus with fluorescence in situ hybridization.
    Leppig KA; Viskochil D; Neil S; Rubenstein A; Johnson VP; Zhu XL; Brothman AR; Stephens K
    Cytogenet Cell Genet; 1996; 72(1):95-8. PubMed ID: 8565646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular genetics of neurofibromatosis type 1 (NF1).
    Shen MH; Harper PS; Upadhyaya M
    J Med Genet; 1996 Jan; 33(1):2-17. PubMed ID: 8825042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.
    Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ
    J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.